Lilly Reinstates Tighter 340B Contract Pharmacy Restrictions

Lilly
Eli Lilly is conducting government approved 340B provider audits that for the first time look for certain Medicaid health plan duplicate discounts.
Pharmaceutical giant Eli Lilly this week announced it would reinstate tighter 340B contract pharmacy restrictions for all covered entity types. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drug Industry Pushes Federal Court to Block Louisiana’s 340B Contract Pharmacy Law Without Trial

Louisiana capitol
PhRMA has asked a federal district judge to block Louisiana's 340B contract pharmacy law, Act 358, which took effect Aug. 1.
An influential drug industry trade group recently urged a federal judge to rule on its suit against Louisiana’s 340B contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Arkansas Urges Federal Court to Reject Novo Nordisk’s Challenge to 340B Contract Pharmacy Law

All drugmaker suits against Arkansas Act 1103 in federal district court should appear before Judge Billy Roy Wilson, AID said in a recent filing.
The Arkansas Insurance Department (AID) recently asked a federal district judge to dismiss Novo Nordisk’s lawsuit that challenges Arkansas’ state [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Sixth Drugmaker Loosens 340B Contract Pharmacy Restrictions in Arkansas and Louisiana

Drugmaker Organon has loosened its 340B contract pharmacy restrictions in Arkansas and Louisiana in response to state laws.
Organon, a Merck spinoff with a focus on women’s health, yesterday became the sixth drugmaker to loosen or end its [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Lobbying Still on Track for Record Year

Darbin Wofford, a health policy advisor at Third Way, said his organization is urging Congressional Democrats to adopt 340B program reforms.
Lobbying on 340B issues in 2023 remains on track for a record-breaking year, according to recently released congressional lobbying reports. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Program May Lead to Lower Charity Care, Says Drug Industry-Backed AIDS Group

Brandon Macsata
Brandon Macsata, CEO of ADAP Advocacy, said the group plans to publish data from its ongoing study on the 340B program later this year.
Enrollment in the 340B program was linked to diminished spending on charity care, according to preliminary findings from an ongoing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Sandoz Is 28th Drugmaker to Adopt 340B Contract Pharmacy Restrictions

Drugmaker Sandoz, a Novartis spin-off, became the 28th pharmaceutical company to implement 340B contract pharmacy restrictions.
Generic and biosimilar drugmaker Sandoz today became the 28th pharmaceutical company to place conditions on 340B pricing involving drug shipments [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

GSK Loosens 340B Contract Pharmacy Restrictions in Arkansas and Louisiana

GSK headquarters
Senderra Rx will no longer dispense GlaxoSmithKline’s asthma drug, Nucala.
GlaxoSmithKline (GSK) today became the fifth drug manufacturer to loosen or end its 340B contract pharmacy restrictions in Arkansas and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Provider-Genentech Lobbying Group Boosts Spending, Adds Members

340B Working Table
More than 360 firms reported lobbying on the 340B program between July 1 and Sept. 30.
Genentech, Sanford Health, and Carolina Health Centers’ 340B reform group, 340B Working Table, spent $110,000 on lobbying and gained eight [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

GSK Adds Drug to Contract Pharmacy Restriction List

GSK headquarters
Senderra Rx will no longer dispense GlaxoSmithKline’s asthma drug, Nucala.
GlaxoSmithKline (GSK) recently restricted 340B pricing on Jesduvroq, an anemia treatment, when providers dispense it through contract pharmacies. GSK contractor [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live